NEW YORK (Reuters) - U.S. stocks dipped on Wednesday to snap a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.
German business confidence unexpectedly rose in April, signaling optimism that Europe's largest economy will withstand risks from tension in Ukraine to price weakness in the euro area.
Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
The euro struggled to make headway on Thursday amid caution before a speech by ECB President Mario Draghi, while the New Zealand dollar rose after the central bank raised interest rates and signalled more tightening.
Demand from homebuyers continues to outpace supply, according to new housing numbers released yesterday, and experts said relief from rising prices and low inventory isn't in sight anytime soon.